Popular weight-loss drugs may lower cancer risk, finds large study |
Exciting new findings indicate that GLP-1 weight-loss medications might dramatically reduce the likelihood of 10 types of cancer linked to obesity for patients with type 2 diabetes, outperforming insulin. However, there’s no observed benefit for postmenopausal breast or thyroid cancers. Weight-loss drugs known as GLP-1 receptor agonists are discussed for their effect on blood sugar…